V2X VVX Effective Income Tax Rate Reconciliation, Tax Credit, Research Net Of Adjustments, Percent

Effective Income Tax Rate Reconciliation, Tax Credit, Research Net Of Adjustments, Percent at other companies

SeaboardSEB

1.5%—

Albany International Inc.AIN

-1.6%—

Vertex, Inc.VERX

$1.13M-8.4%

HTF

Heartflow, Inc. Common StockHTFL

0.3%—

AbCellera Biologics Inc.ABCL

-3.4%—

Oruka Therapeutics, Inc.ORKA

-2%-0.6pp

Other financials

Income statement

See full

Revenue$1.3B+23.4%

Gross profit$105.8M+35.5%

Operating income$44.1M+28.5%

Net income$18.9M+133%

EPS (diluted)$0.60+140%

Balance sheet

See full

Cash & equivalents$208.7M+23.4%

Total debt$1.1B-5.8%

Total equity$1.1B+6.5%

Total assets$3.2B+2.8%

Cash flow

See full

Operating cash flow-$129.9M-36.1%

CapEx$2.3M-15.1%

Free cash flow-$132.2M-34.7%

Valuation

See full

Market cap$2.61B+38.2%

Enterprise value$3.48B+19.3%

P/E29.4×-15.9×

P/S0.6×+0.1×

Profitability

See full

Gross margin8.5%+0.4pp

Operating margin4.3%+0.6pp

Net margin1.9%+0.9pp

FCF margin4.8%+1.2pp

Returns & leverage

See full

Return on equity8.3%+4.2pp

Debt / equity1×-0.1×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by V2X in its filing.

Tagged under the XBRL concept vec:EffectiveIncomeTaxRateReconciliationTaxCreditResearchNetOfAdjustmentsPercent.

The official record: V2X’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about V2X's effective income tax rate reconciliation, tax credit, research net of adjustments, percent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is V2X's effective income tax rate reconciliation, tax credit, research net of adjustments, percent?: V2X (VVX) reported effective income tax rate reconciliation, tax credit, research net of adjustments, percent of -0.1% in Q4 2025.
What does effective income tax rate reconciliation, tax credit, research net of adjustments, percent mean?: This represents the percentage point reduction in the effective tax rate attributable to research and development tax credits. It quantifies the relative benefit of innovation-related tax incentives on the company's bottom line. Investors use this to gauge the effectiveness of R&D spending in optimizing the company's tax position.